For Immediate Release

Chicago, IL – November 16, 2009 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Apple Inc. (AAPL), Microsoft Corp (MSFT), Quality Systems Inc. (QSII), Allscripts-Misys Healthcare Solutions, Inc. (MDRX) and Cerner Corp. (CERN).

Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=5513

Here are highlights from Friday’s Analyst Blog:

Apple Opens New Store in New York

Apple Inc. (AAPL) will open its newest retail store with an 8,500 square feet retail space in New York tomorrow. The store will help Apple deliver more Macs, iPods and iPhones, taking advantage of the coming holiday

...

Apple Inc. (AAPL) will open its newest retail store with an 8,500 square feet retail space in New York tomorrow. The store will help Apple deliver more Macs, iPods and iPhones, taking advantage of the coming holiday season. The new store is the fourth in Manhattan and fifteenth in New York.   To ensure a high-quality buying experience for its products, in which service and education are emphasized, the company has expanded and improved its distribution capabilities by opening its own retail stores in the U.S. and internationally.   The company operates a network of 280 retail stores in 10 countries across the world, including the U.S., U.K., Italy, Australia, Canada, Japan, China, Switzerland, Germany and France to drive the demand for its other products. Further, Apple is soon to open two new stores in Shanghai as well as London and Paris. The company further plans to ...

Dr Stock Pick HOT News & Alerts!

_______________________________________

FREE Daily Stock Alerts From DrStockPick.com

_______________________________________

Thursday November 5, 2009

DrStockPick.com Stock Report!

**************************************************************

Cavitation Technologies, Inc. (OTC Bulletin Board: CVAT) announced recently that it has signed Miura Engineering Co., Ltd. Tokyo, Japan (www.miura21.co.jp) as its new agent to serve markets in Japan for CTI’s Nano-Cavitation Process Systems. Miura is a leading Engineering Company specialized in Edible Oil Processing Plants in the Far East. Last week CVAT reported a 3-for-1 forward stock split.

IRIDEX Corporation (Nasdaq: IRIX) today announced that it will release its third quarter 2009 financial results after the

...

Dr Stock Pick HOT News & Alerts!

_______________________________________

FREE Daily Stock Alerts From DrStockPick.com

_______________________________________

Wednesday October 7, 2009

DrStockPick.com Stock Report!

**************************************************************

International Aerospace Enterprises, Inc. (OTCBB: IARO) today announced that IARO’s President Saffet Uslu has returned to the US from a successful Middle East sales and marketing trip. During the trip he had an opportunity to meet with governmental agencies, commercial companies working with military aircraft spare parts projects, and private marketing companies who have all voiced an interest in joining IARO’s Strategic Worldwide Sales and Marketing Program.

Center Bancorp, Inc. (Nasdaq:CNBC), parent company of Union Center National Bank

...

CareView Communications, Inc. Announces Relocation to Larger Office/Warehouse Facility in Lewisville, Texas

CareView Communications, Inc. (“CareView” or the “Company”) (Pink Sheets: CRVW), an information technology provider to the healthcare industry, announced today that it is relocating to a new office warehouse complex as of October 1, 2009. Located at the intersection of State Highway 121 and Interstate Highway 35 in Lewisville, Texas, this facility will accommodate CareView’s expanding operations as well as being located closer to the Dallas/Fort Worth International Airport. The new facility provides almost 40% more square footage than the current location. In addition to more adequate office and meeting space, the new facility will have warehouse space and equipment testing labs to allow CareView to design, develop and provide quality assurance for its CareView System™ product, and will allow for a larger and more efficient assembly area for the server systems CareView uses in its hospitals.

About CareView

...

Dr Stock Pick HOT News & Alerts!

_________________________________________

FREE Daily Stock Alerts From DrStockPick.com

_________________________________________

 

Tuesday September 15, 2009

DrStockPick.com Stock Report!

PWRM, NWMT, CVAT, CSRH, CCTR, NUBL, SPNG, IOPM, AQNM, TSPG

**************************************************************

PWRM, Power 3 Medical Products Inc, PWRM.OB

PWRM is a leading bio-medical company engaged in the commercialization of neurodegenerative disease and cancer biomarkers, pathways, and mechanisms of diseases through the development of diagnostic tests and drug targets.

PWRM’s NuroPro PD test was developed to help clinicians distinguish patients with Parkinson’s disease from “normal” individuals and patients with other neurological disorders. The NuroPro PD test, developed by Power3, utilizes a panel of blood serum protein biomarkers evaluated by biostatistical analysis to predict the probability that

...

 

PennyOmega.com Hot Stock News & Alerts!

________________________________________

FREE Daily Stock Alerts From PennyOmega.com

________________________________________

 

Friday September 4, 2009

PennyOmega.com Stock Report!

**************************************************************

Callidus Software Inc. (NASDAQ: CALD), the leader in Sales Performance Management (SPM), today announced that Medical Mutual of Ohio has selected Callidus Software’s Insurance Suite and Business Process Management Suite (BPM) to manage its sales performance, incentive compensation programs and broker onboarding processes. Under the agreement, signed in the third quarter

...

The battle for the smart phone market is heating up this year because the smart phone market is the only game in town. Although smart phones account for just 1 in every 7 mobile devices sold, this segment has doubled its share of the global mobile phone business over the past three years. Revenues from smart phones are expected to double, to half the industry total, by 2014.

Recent figures from market research company Gartner confirm this trend. Gartner’s figures showed that shipments of phones that allow web surfing, email and other popular software applications rose 27 percent in the second quarter to 41 million units. This occurred even while overall handset sales remained on track for their first full-year decline ever. For the three months to June 20, overall mobile phone sales fell 6.1 percent to 286.1 million units. Even during the recession it seems consumers are abandoning ‘dumb’ phones

...

DrStockPick.com Stock Report!

Tuesday August 18, 2009

**************************************************************

Aruba Networks, Inc. (NASDAQ: ARUN), a global leader in wireless LANs and secure mobility solutions, today announced that it is the first wireless LAN vendor to have its 802.11n solution and ArubaOS Release 3 validated within the FIPS 140-2 Federal Information Processing Standard for cryptographic security. The validation encompasses Aruba’s 200, 800, 3000 and 6000 Series Multi-Service Mobility Controllers, 802.11a/b/g/n indoor and outdoor access points, resilient mesh software, and Remote Access Point (RAP) technology. Leveraging field-proven hardware platforms and software applications allows Aruba to deliver a rich feature set with predictable performance, avoiding the throughput bottlenecks, degraded reliability, management issues, and added expense

...

CRWENewswire.com is pleased to announce a stock highlight on Celgene Corporation (Nasdaq: CELG), Monotype Imaging Holdings Inc. (Nasdaq: TYPE), Royale Energy Inc (NASDAQ:ROYL)

Celgene Corporation (Nasdaq: CELG) today August 5, 2009 announced that the National Comprehensive Cancer Network (NCCN) has updated its Clinical Practice Guidelines in Oncology™ v1.2010 and has upgraded VIDAZA® to a Category 1 recommended treatment for patients with intermediate-2 and high-risk myelodysplastic syndromes (MDS).

About VIDAZA® In December 2008, VIDAZA became the first and only drug approved by the European Commission to demonstrate a significant extension of overall survival compared to conventional care regimens, for patients with Intermediate-2 and high-risk MDS and AML

About Myelodysplastic Syndromes Myelodysplastic syndromes (MDS) are a group of hematologic malignancies that affect approximately 300,000 people worldwide. Myelodysplastic syndromes occur when blood cells remain in an immature or “blast” stage within the bone marrow and never develop into mature cells capable of performing their necessary functions.

Monotype

...